Marijuana, cannabinoids and other psychoactive substances in the light of modern medicine. Facts and Myths 1600-OG-EN-MCAOP

1. Overview of the endocannabinoid system.
2. Analysis of reports on the effects of activation of cannabinoid receptors in selected disease entities.
3. Prospects for future applications and related controversies.
4. Risk of addiction.
5. Potential use of other psychoactive substances in therapy.

Całkowity nakład pracy studenta

Contact hours with teacher: - participation in seminars - 20 hrs - consultations - 5 hrs Self-study hours: - preparation for seminars - 10hrs - reading literature - 10 hrs - preparation for examination - 5 hrs Altogether: 50 hrs (2 ECTS)

Efekty uczenia się - wiedza

W1: knows the fundamental principles of pharmacotherapy C.W38 W2: knows symptoms of the most common acute poisonings, including poisoning with alcohol, drugs, psychoactive substances, heavy metals and selected drug groups C.W45 W3: basic methods of statistical analysis used in population studies and diagnostic assays B.W27

Efekty uczenia się - umiejętności

U1: select drugs and their appropriate doses in order to correct pathological changes in the organism and in individual organs C.U14 U2: perform an analysis of possible adverse effects of individual drugs and drug interactions E.U17 U3: in case of ineffectiveness of or contraindications to standard therapy, propose the individualization of currently accepted therapeutic guidelines and other treatment methods E. U17

Efekty uczenia się - kompetencje społeczne

K1: ability to use objective sources of information; K_K01 K2: ability to formulate opinions based on own assessment and observation; K_K.10

Metody dydaktyczne

- informative lecture - participatory lecture

Rodzaj przedmiotu

przedmiot fakultatywny

Wymagania wstępne

none

Koordynatorzy przedmiotu

W cyklu 2023/24L:

W cyklu 2025/26L:

W cyklu 2022/23L:

W cyklu 2024/25L:

Kryteria oceniania

Assessment methods:
- a final essay

Assessment criteria:
- non-graded credit

Praktyki zawodowe

not applicable

Literatura

1. Farmakologia i toksykologia E. Mutschlera PZWL
2. Zou, S., & Kumar, U. (2018). Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. International journal of molecular sciences, 19(3), 833.
3. Giacoppo, S., Mandolino, G., Galuppo, M., Bramanti, P., & Mazzon, E. (2014). Cannabinoids: new promising agents in the treatment of neurological diseases. Molecules, 19(11), 18781-18816.
4. An, D., Peigneur, S., Hendrickx, L. A., & Tytgat, J. (2020). Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. International Journal of Molecular Sciences, 21(14), 5064.
5. McCoy, K. L. (2016). Interaction between cannabinoid system and toll-like receptors controls inflammation. Mediators of inflammation, 2016.
6. Chakravarti, B., Ravi, J., & Ganju, R. K. (2014). Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget, 5(15), 5852.
7. Kwan Cheung, K. A., Peiris, H., Wallace, G., Holland, O. J., & Mitchell, M. D. (2019). The interplay between the endocannabinoid system, epilepsy and cannabinoids. International Journal of Molecular Sciences, 20(23), 6079.
8. Scheau, C., Badarau, I. A., Mihai, L. G., Scheau, A. E., Costache, D. O., Constantin, C., ... & Caruntu, A. (2020). Cannabinoids in the Pathophysiology of Skin Inflammation. Molecules, 25(3), 652.

Więcej informacji

Dodatkowe informacje (np. o kalendarzu rejestracji, prowadzących zajęcia, lokalizacji i terminach zajęć) mogą być dostępne w serwisie USOSweb:

Strona przedmiotu 1600-OG-EN-MCAOP w USOSweb